stella
beta
Neoadjuvant Pembrolizumab and IO102-103 for Squamous Cell Carcinoma of the Head and Neck (SCCHN). — Stella
Recruiting
Back to Head and Neck Squamous Cell Carcinoma trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(5 sites)
United States
Sibley Memorial Hospital, Washington D.C., District of Columbia
Northwestern Memorial Hospital, Chicago, Illinois
Johns Hopkins University, Baltimore, Maryland
Providence Cancer Institute, Portland, Oregon
Thomas Jefferson University Hospital, Philadelphia, Pennsylvania
View full record on ClinicalTrials.gov